The medical sector is rapidly evolving as new technologies and scientific breakthroughs challenge traditional standards of ...
Ho Ho Haunted! It's no secret that the holiday season is the most magical time of the year... but in Dallas, it's also the spookiest one too. Baymo, the creative masterminds behind the long-running ...
The Leica Q3 Monochrom renders the world in deep, expressive black and white, offering tonality and dynamic range that color ...
Proximity, the all-in-one Retail Super-App used by Max Mara, Joseph, Paul Smith, Graff, and Farrow & Ball, has launched Message Maestro, a new Generative AI-powered feature that makes personalised ...
The top match on the 12th matchday of the Bundesliga will be played today between Bayer Leverkusen and BVB. Here is where to ...
Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of its buyout of Vividion Therapeutics. The Vividion asset in question, called ...
The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – a fall of around 12% since the start of 2024 – and isn't yet completed. On the German ...
Bayer is reshaping its pharmaceutical business with a new operating model designed to enhance collaboration and bring research & development and commercialization closer together. In a recent episode ...
Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway. The first patient has already been treated with bemdaneprocel, a ...
Bayern Munich are overwhelming favourites to win the Bundesliga title, and it is hard to see anyone keeping pace with them over the course of a 34-game campaign. If anyone can, though, it will ...
Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...
A federal judge in San Francisco gave final approval to a $38 million class action settlement in a case against Bayer over investors’ claims that it didn’t conduct due diligence before making a ...